It’s no secret that due diligence is a complicated matter, and as competition continues to increase in the private equity (PE) space, qualified targets are becoming harder to find. To compete, investors need to be smarter about the nuances of the seller’s company and industry and be able to read the tea leaves.
For Ken Sipiora, a senior advisor with 39 years’ experience, the best calls with Apex Leaders’ private equity clients have been the ones in which clients know—and can articulate—their end game and any obstacles to getting there.
It is no secret that competition has ramped up in private equity, as new players—corporations, more private equity firms, and non-traditional investors—have entered the market, making it harder to find qualified targets. Private equity firms alone have grown by leaps and bounds over the last 20 years; around 5,000 firms now operate around the...
Beyond the C-level executive formerly at a target company, who else should investors tap for a unique perspective?
Changes to The Affordable Care Act (ACA) will have a profound impact on more than 20 million people who found health insurance under this law. Yet of the entire affected healthcare industry, certain sectors, like mental health and substance use, are facing a different reality under the Trump Administration.
How do you replicate the results of an insightful advisor consultation?
Primary research firms like Apex Leaders scour sites like LinkedIn for seasoned industry experts or subject matter experts to advise top-tier Private Equity investors who value experts’ guidance during their investment due diligence process. PE investors are increasingly turning to such firms to help identify key people to influence their...
Your initial conversation with a PE investor is crucial—it sets the tone for your working relationship and establishes you as a trusted, professional advisor with the expertise they need.
Before diving into the data, understand the industry
Ed Jones, Ph.D., is a clinical psychologist with extensive experience in the clinical and business aspects of healthcare. His areas of expertise include inpatient and outpatient care in mental health and chemical dependency treatment. He has held leadership roles, including division...